{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:34:35Z","timestamp":1793468075366,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG 2633"],"award-info":[{"award-number":["RTG 2633"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.autrev.2023.103386","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:43:38Z","timestamp":1687369418000},"page":"103386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Functional autoantibodies: Definition, mechanisms, origin and contributions to autoimmune and non-autoimmune disorders"],"prefix":"10.1016","volume":"22","author":[{"given":"Xinhua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Wax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl 2","key":"10.1016\/j.autrev.2023.103386_bb0005","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2007.06.001","article-title":"Functional autoantibodies, a new paradigm in autoimmunity?","volume":"7","author":"Gleicher","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2023.103386_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-18-7-699","article-title":"The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients","volume":"18","author":"Adams","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1073\/pnas.52.2.342","article-title":"Characterization of the long-acting thyroid stimulator of Graves\u2019 disease","volume":"52","author":"Meek","year":"1964","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1677\/joe.0.0750401","article-title":"Interaction of thyroid-stimulating antibodies with the human thyrotrophin receptor","volume":"75","author":"Smith","year":"1977","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09537104.2016.1214253","article-title":"Prognostic significance of platelet count in SLE patients","volume":"28","author":"Abdel Galil","year":"2017","journal-title":"Platelets"},{"issue":"11","key":"10.1016\/j.autrev.2023.103386_bb0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2017.134","article-title":"Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases","volume":"13","author":"Cabral-Marques","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"7866","key":"10.1016\/j.autrev.2023.103386_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103386_bb0050","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.18.1.739","article-title":"Multiple roles for the major histocompatibility complex class I- related receptor FcRn","volume":"18","author":"Ghetie","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.RES.64.1.97","article-title":"Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy","volume":"64","author":"Limas","year":"1989","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.autrev.2023.103386_bb0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103386_bb0065","doi-asserted-by":"crossref","first-page":"103310","DOI":"10.1016\/j.autrev.2023.103310","article-title":"Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium","volume":"22","author":"Cabral-Marques","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"7930","key":"10.1016\/j.autrev.2023.103386_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(75)92779-8","article-title":"Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis","volume":"2","author":"Aharonov","year":"1975","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.autrev.2023.103386_bb0075","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103386_bb0085","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/epi4.12067","article-title":"Pathogenic potential of antibodies to the GABA(B) receptor","volume":"2","author":"Nibber","year":"2017","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0095","article-title":"Anticytokine autoantibodies: Association with infection and immune dysregulation","volume":"5","author":"Knight","year":"2016","journal-title":"Antibodies (Basel)"},{"issue":"16","key":"10.1016\/j.autrev.2023.103386_bb0100","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2009-12-258780","article-title":"The ADAMTS13 metalloprotease domain: Roles of subsites in enzyme activity and specificity","volume":"116","author":"de Groot","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.autrev.2023.103386_bb0105","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"issue":"20","key":"10.1016\/j.autrev.2023.103386_bb0110","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.2621","article-title":"Dysregulation of immune homeostasis in autoimmune diseases","volume":"18","author":"Kuchroo","year":"2012","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.autrev.2023.103386_bb0120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.autrev.2017.04.006","article-title":"Dysregulated homeostasis of target tissues or autoantigens - A novel principle in autoimmunity","volume":"16","author":"Petersen","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2023.103386_bb0125","doi-asserted-by":"crossref","first-page":"103287","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0130","doi-asserted-by":"crossref","first-page":"103230","DOI":"10.1016\/j.autrev.2022.103230","volume":"22","author":"Malkova","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","article-title":"Thymoma, myasthenia gravis, and other paraneoplastic syndromes","volume":"22","author":"Tormoehlen","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.autrev.2023.103386_bb0140","first-page":"474512","article-title":"Thymoma in myasthenia gravis: From diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0145","first-page":"865","article-title":"Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis","volume":"134","author":"Marx","year":"1989","journal-title":"Am J Pathol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2023.103386_bb0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(02)00145-5","article-title":"Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules","volume":"128","author":"Romi","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0160","doi-asserted-by":"crossref","first-page":"102422","DOI":"10.1016\/j.autrev.2019.102422","article-title":"Aetiology and pathogenesis of paraneoplastic autoimmune disorders","volume":"19","author":"Geng","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0170","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000529","article-title":"Mouse model of anti-NMDA receptor post-herpes simplex encephalitis","volume":"6","author":"Linnoila","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"10.1016\/j.autrev.2023.103386_bb0175","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/dmcn.13448","article-title":"Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: A systematic literature review with analysis of 43 cases","volume":"59","author":"Nosadini","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103386_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/08916930802031702","article-title":"Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas\u2019 heart disease","volume":"41","author":"Levin","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2023.103386_bb0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-422X-6-5","article-title":"Viruses and thyroiditis: An update","volume":"6","author":"Desailloud","year":"2009","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","article-title":"An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains","volume":"17","author":"Finnish-German","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2023.103386_bb0195","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fimmu.2017.00976","article-title":"Autoantibody repertoire in APECED patients targets two distinct subgroups of proteins","volume":"8","author":"Fishman","year":"2017","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103386_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0215","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/2042018811408488","article-title":"Current concepts in graves\u2019 disease","volume":"2","author":"Girgis","year":"2011","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.autrev.2023.103386_bb0230","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1210\/jc.2003-032068","article-title":"Affinity-enrichment of thyrotropin receptor autoantibodies from Graves\u2019 patients and normal individuals provides insight into their properties and possible origin from natural antibodies","volume":"89","author":"Latrofa","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0235","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1172\/JCI114768","article-title":"Thyroid-stimulating antibody activity between different immunoglobulin G subclasses","volume":"86","author":"Weetman","year":"1990","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2023.103386_bb0240","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-46-5-734","article-title":"Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis","volume":"46","author":"Endo","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0245","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2010.03831.x","article-title":"Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample","volume":"73","author":"Evans","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0250","first-page":"447","article-title":"Graves\u2019 hyperthyroidism following primary hypothyroidism: Sequential changes in various activities of thyrotropin receptor antibodies","volume":"120","author":"Cho","year":"1989","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.autrev.2023.103386_bb0255","doi-asserted-by":"crossref","first-page":"182176","DOI":"10.1155\/2012\/182176","volume":"2012","author":"Takasu","year":"2012","journal-title":"J Thyroid Res"},{"issue":"11","key":"10.1016\/j.autrev.2023.103386_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: Epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103386_bb0265","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0270","first-page":"82","article-title":"Acetylcholine receptor antibody in myasthenia gravis: Predominance of IgG subclasses 1 and 3","volume":"67","author":"Rodgaard","year":"1987","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0275","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J Exp Med"},{"issue":"13","key":"10.1016\/j.autrev.2023.103386_bb0280","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103386_bb0290","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2023.103386_bb0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0300","doi-asserted-by":"crossref","first-page":"102988","DOI":"10.1016\/j.autrev.2021.102988","article-title":"Autoimmune autonomic ganglionopathy: Ganglionic acetylcholine receptor autoantibodies","volume":"21","author":"Urriola","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2023.103386_bb0305","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2023.103386_bb0310","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI17429","article-title":"Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease","volume":"111","author":"Lennon","year":"2003","journal-title":"J Clin Invest"},{"issue":"32","key":"10.1016\/j.autrev.2023.103386_bb0315","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1523\/JNEUROSCI.1485-04.2004","article-title":"Passive transfer of autoimmune autonomic neuropathy to mice","volume":"24","author":"Vernino","year":"2004","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0320","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1152\/jn.00408.2003","article-title":"Experimental autoimmune autonomic neuropathy","volume":"90","author":"Vernino","year":"2003","journal-title":"J Neurophysiol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103386_bb0325","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.autrev.2023.103386_bb0330","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.202112-2742SO","article-title":"Autoimmune pulmonary alveolar proteinosis","volume":"205","author":"McCarthy","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"10.1016\/j.autrev.2023.103386_bb0335","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM195806052582301","article-title":"Pulmonary alveolar proteinosis","volume":"258","author":"Rosen","year":"1958","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.autrev.2023.103386_bb0340","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2008-05-155689","article-title":"Granulocyte\/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects","volume":"113","author":"Uchida","year":"2009","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.autrev.2023.103386_bb0345","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure red cell aplasia","volume":"128","author":"Means","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.autrev.2023.103386_bb0350","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM199603073341004","article-title":"Autoantibodies against erythropoietin in a patient with pure red-cell aplasia","volume":"334","author":"Casadevall","year":"1996","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2023.103386_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jim.2012.05.013","article-title":"Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing","volume":"382","author":"Mytych","year":"2012","journal-title":"J Immunol Methods"},{"issue":"Pt 10","key":"10.1016\/j.autrev.2023.103386_bb0360","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.autrev.2023.103386_bb0365","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.autrev.2023.103386_bb0370","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"Tuzun","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0380","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103386_bb0385","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0390","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"10.1016\/j.autrev.2023.103386_bb0395","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0400","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40478-016-0397-1","article-title":"Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders","volume":"4","author":"Sinmaz","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0405","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"issue":"14","key":"10.1016\/j.autrev.2023.103386_bb0410","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: Main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.autrev.2023.103386_bb0415","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa","year":"2014","journal-title":"J Neurosci"},{"issue":"18","key":"10.1016\/j.autrev.2023.103386_bb0420","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0425","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"22","key":"10.1016\/j.autrev.2023.103386_bb0430","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis with mGluR5 antibodies: Symptoms and antibody effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.autrev.2023.103386_bb0435","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","article-title":"Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development","volume":"86","author":"Gresa-Arribas","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103386_bb0440","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: Pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"issue":"22","key":"10.1016\/j.autrev.2023.103386_bb0445","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM198906013202206","article-title":"The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem)","volume":"320","author":"Rock","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0450","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jid.2017.06.022","article-title":"Mechanisms causing loss of keratinocyte cohesion in pemphigus","volume":"138","author":"Spindler","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0455","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1172\/JCI114426","article-title":"Monovalent Fab\u2019 immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb\/c mice","volume":"85","author":"Rock","year":"1990","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1016\/j.autrev.2023.103386_bb0460","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"issue":"6855","key":"10.1016\/j.autrev.2023.103386_bb0465","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.autrev.2023.103386_bb0470","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): A cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"issue":"22","key":"10.1016\/j.autrev.2023.103386_bb0475","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0480","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"10.1016\/j.autrev.2023.103386_bb0485","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.0000084543.79097.34","article-title":"Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure","volume":"108","author":"Horwich","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0735-1097(99)00485-4","article-title":"Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis","volume":"35","author":"Lauer","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0495","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCULATIONAHA.106.683193","article-title":"Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis","volume":"116","author":"Jane-wit","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.autrev.2023.103386_bb0500","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","article-title":"Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy","volume":"113","author":"Jahns","year":"2004","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0505","doi-asserted-by":"crossref","first-page":"14552","DOI":"10.1038\/s41598-019-51125-9","article-title":"Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome","volume":"9","author":"Ernst","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103386_bb0510","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcvm.2018.00170","article-title":"Beta-1-adrenergic receptor antibodies in acute coronary syndrome: Is less sometimes more?","volume":"5","author":"Ernst","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"10103","key":"10.1016\/j.autrev.2023.103386_bb0515","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.autrev.2023.103386_bb0520","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0525","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0530","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","article-title":"Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis","volume":"60","author":"Classen","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0535","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","article-title":"Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera","volume":"60","author":"Loizos","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2023.103386_bb0540","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Gunther","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0545","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2023.103386_bb0550","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/annrheumdis-2021-222088","article-title":"Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching","volume":"81","author":"Yue","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103386_bb0555","doi-asserted-by":"crossref","first-page":"102527","DOI":"10.1016\/j.autrev.2020.102527","article-title":"A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): Recognitions from the finding of autoantibodies against ss2-adrenergic receptors","volume":"19","author":"Wirth","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2023.103386_bb0560","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2741\/4689","article-title":"Autoantibodies against muscarinic acetylcholine receptor M(3) in Sjogren\u2019s syndrome and corresponding mouse models","volume":"23","author":"Yu","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"10.1016\/j.autrev.2023.103386_bb0565","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/eji.201747209","article-title":"IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model","volume":"48","author":"Bichele","year":"2018","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103386_bb0570","doi-asserted-by":"crossref","first-page":"103071","DOI":"10.1016\/j.autrev.2022.103071","article-title":"The autonomic aspects of the post-COVID19 syndrome","volume":"21","author":"Dotan","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"6515","key":"10.1016\/j.autrev.2023.103386_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"62","key":"10.1016\/j.autrev.2023.103386_bb0580","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103386_bb0585","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10875-021-01136-x","article-title":"Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in Barcelona","volume":"41","author":"Solanich","year":"2021","journal-title":"J Clin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103386_bb0590","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220514","article-title":"Autoantibodies against type I IFNs in patients with critical influenza pneumonia","volume":"219","author":"Zhang","year":"2022","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103386_bb0595","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-022-28905-5","article-title":"Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity","volume":"13","author":"Cabral-Marques","year":"2022","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.autrev.2023.103386_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137209","article-title":"Long COVID: Association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation","volume":"23","author":"Szewczykowski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103386_bb0605","doi-asserted-by":"crossref","first-page":"100100","DOI":"10.1016\/j.jtauto.2021.100100","article-title":"Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms","volume":"4","author":"Wallukat","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"4437","key":"10.1016\/j.autrev.2023.103386_bb0610","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.6153472","article-title":"Autoantibodies to beta 2-adrenergic receptors: A possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma","volume":"207","author":"Venter","year":"1980","journal-title":"Science"},{"issue":"3 Pt 1","key":"10.1016\/j.autrev.2023.103386_bb0615","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0091-6749(84)90253-7","article-title":"Beta-blocking autoantibodies in pediatric bronchial asthma","volume":"74","author":"Blecher","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103386_bb0620","first-page":"248","article-title":"Atopy, autonomic function and beta-adrenergic receptor autoantibodies","volume":"90","author":"Harrison","year":"1982","journal-title":"Ciba Found Symp"},{"issue":"4","key":"10.1016\/j.autrev.2023.103386_bb0625","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.202206-1183OC","article-title":"Autoantibody-mediated macrophage dysfunction in patients with severe asthma with airway infections","volume":"207","author":"Son","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2023.103386_bb0630","doi-asserted-by":"crossref","first-page":"108512","DOI":"10.1016\/j.clim.2020.108512","article-title":"Neutralizing natural anti-IL-17F autoantibodies protect autoimmune polyendocrine syndrome type 1 (APS-1) patients from asthma","volume":"219","author":"Jokinen","year":"2020","journal-title":"Clin Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:54Z","timestamp":1761600474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":126,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1568997223001209"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103386","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional autoantibodies: Definition, mechanisms, origin and contributions to autoimmune and non-autoimmune disorders","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103386"}}